Summary

According to this study, the global CGRP Inhibitor market size will reach US$ 4547 million by 2031.
CGRP inhibitors are a class of medications that block the activity of calcitonin gene-related peptide (CGRP), a neuropeptide involved in the pathophysiology of migraines. By targeting either the CGRP ligand or its receptor, these drugs prevent the dilation of blood vessels and inflammation associated with migraine attacks. CGRP inhibitors are used primarily for the prevention and acute treatment of migraines and include monoclonal antibodies (e.g., erenumab, fremanezumab, galcanezumab) and small molecule receptor antagonists (gepants). They are generally well tolerated and represent a significant advancement in migraine therapy.
United States market for CGRP Inhibitor is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for CGRP Inhibitor is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for CGRP Inhibitor is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key CGRP Inhibitor players cover AbbVie, Amgen, Eli Lilly, Teva Pharmaceutical, Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “CGRP Inhibitor Industry Forecast” looks at past sales and reviews total world CGRP Inhibitor sales in 2024, providing a comprehensive analysis by region and market sector of projected CGRP Inhibitor sales for 2025 through 2031. With CGRP Inhibitor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CGRP Inhibitor industry.
This Insight Report provides a comprehensive analysis of the global CGRP Inhibitor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CGRP Inhibitor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CGRP Inhibitor market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CGRP Inhibitor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CGRP Inhibitor.
This report presents a comprehensive overview, market shares, and growth opportunities of CGRP Inhibitor market by product type, application, key players and key regions and countries.
Segmentation by Type:
Infusions
Oral
Other
Segmentation by Application:
Hospital
Retail Pharmacy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AbbVie
Amgen
Eli Lilly
Teva Pharmaceutical
Pfizer
Lundbeck
Novartis
Bristol Myers Squibb
Satsuma
Zosano Pharma
Dr.Reddy’s Laboratories

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CGRP Inhibitor Market Size (2020-2031)
2.1.2 CGRP Inhibitor Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for CGRP Inhibitor by Country/Region (2020, 2024 & 2031)
2.2 CGRP Inhibitor Segment by Type
2.2.1 Infusions
2.2.2 Oral
2.2.3 Other
2.3 CGRP Inhibitor Market Size by Type
2.3.1 CGRP Inhibitor Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global CGRP Inhibitor Market Size Market Share by Type (2020-2025)
2.4 CGRP Inhibitor Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Others
2.5 CGRP Inhibitor Market Size by Application
2.5.1 CGRP Inhibitor Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global CGRP Inhibitor Market Size Market Share by Application (2020-2025)
3 CGRP Inhibitor Market Size by Player
3.1 CGRP Inhibitor Market Size Market Share by Player
3.1.1 Global CGRP Inhibitor Revenue by Player (2020-2025)
3.1.2 Global CGRP Inhibitor Revenue Market Share by Player (2020-2025)
3.2 Global CGRP Inhibitor Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CGRP Inhibitor by Region
4.1 CGRP Inhibitor Market Size by Region (2020-2025)
4.2 Global CGRP Inhibitor Annual Revenue by Country/Region (2020-2025)
4.3 Americas CGRP Inhibitor Market Size Growth (2020-2025)
4.4 APAC CGRP Inhibitor Market Size Growth (2020-2025)
4.5 Europe CGRP Inhibitor Market Size Growth (2020-2025)
4.6 Middle East & Africa CGRP Inhibitor Market Size Growth (2020-2025)
5 Americas
5.1 Americas CGRP Inhibitor Market Size by Country (2020-2025)
5.2 Americas CGRP Inhibitor Market Size by Type (2020-2025)
5.3 Americas CGRP Inhibitor Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CGRP Inhibitor Market Size by Region (2020-2025)
6.2 APAC CGRP Inhibitor Market Size by Type (2020-2025)
6.3 APAC CGRP Inhibitor Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe CGRP Inhibitor Market Size by Country (2020-2025)
7.2 Europe CGRP Inhibitor Market Size by Type (2020-2025)
7.3 Europe CGRP Inhibitor Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CGRP Inhibitor by Region (2020-2025)
8.2 Middle East & Africa CGRP Inhibitor Market Size by Type (2020-2025)
8.3 Middle East & Africa CGRP Inhibitor Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global CGRP Inhibitor Market Forecast
10.1 Global CGRP Inhibitor Forecast by Region (2026-2031)
10.1.1 Global CGRP Inhibitor Forecast by Region (2026-2031)
10.1.2 Americas CGRP Inhibitor Forecast
10.1.3 APAC CGRP Inhibitor Forecast
10.1.4 Europe CGRP Inhibitor Forecast
10.1.5 Middle East & Africa CGRP Inhibitor Forecast
10.2 Americas CGRP Inhibitor Forecast by Country (2026-2031)
10.2.1 United States Market CGRP Inhibitor Forecast
10.2.2 Canada Market CGRP Inhibitor Forecast
10.2.3 Mexico Market CGRP Inhibitor Forecast
10.2.4 Brazil Market CGRP Inhibitor Forecast
10.3 APAC CGRP Inhibitor Forecast by Region (2026-2031)
10.3.1 China CGRP Inhibitor Market Forecast
10.3.2 Japan Market CGRP Inhibitor Forecast
10.3.3 Korea Market CGRP Inhibitor Forecast
10.3.4 Southeast Asia Market CGRP Inhibitor Forecast
10.3.5 India Market CGRP Inhibitor Forecast
10.3.6 Australia Market CGRP Inhibitor Forecast
10.4 Europe CGRP Inhibitor Forecast by Country (2026-2031)
10.4.1 Germany Market CGRP Inhibitor Forecast
10.4.2 France Market CGRP Inhibitor Forecast
10.4.3 UK Market CGRP Inhibitor Forecast
10.4.4 Italy Market CGRP Inhibitor Forecast
10.4.5 Russia Market CGRP Inhibitor Forecast
10.5 Middle East & Africa CGRP Inhibitor Forecast by Region (2026-2031)
10.5.1 Egypt Market CGRP Inhibitor Forecast
10.5.2 South Africa Market CGRP Inhibitor Forecast
10.5.3 Israel Market CGRP Inhibitor Forecast
10.5.4 Turkey Market CGRP Inhibitor Forecast
10.6 Global CGRP Inhibitor Forecast by Type (2026-2031)
10.7 Global CGRP Inhibitor Forecast by Application (2026-2031)
10.7.1 GCC Countries Market CGRP Inhibitor Forecast
11 Key Players Analysis
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie CGRP Inhibitor Product Offered
11.1.3 AbbVie CGRP Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen CGRP Inhibitor Product Offered
11.2.3 Amgen CGRP Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly CGRP Inhibitor Product Offered
11.3.3 Eli Lilly CGRP Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Eli Lilly Main Business Overview
11.3.5 Eli Lilly Latest Developments
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Information
11.4.2 Teva Pharmaceutical CGRP Inhibitor Product Offered
11.4.3 Teva Pharmaceutical CGRP Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Teva Pharmaceutical Main Business Overview
11.4.5 Teva Pharmaceutical Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer CGRP Inhibitor Product Offered
11.5.3 Pfizer CGRP Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Lundbeck
11.6.1 Lundbeck Company Information
11.6.2 Lundbeck CGRP Inhibitor Product Offered
11.6.3 Lundbeck CGRP Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Lundbeck Main Business Overview
11.6.5 Lundbeck Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis CGRP Inhibitor Product Offered
11.7.3 Novartis CGRP Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 Bristol Myers Squibb
11.8.1 Bristol Myers Squibb Company Information
11.8.2 Bristol Myers Squibb CGRP Inhibitor Product Offered
11.8.3 Bristol Myers Squibb CGRP Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Bristol Myers Squibb Main Business Overview
11.8.5 Bristol Myers Squibb Latest Developments
11.9 Satsuma
11.9.1 Satsuma Company Information
11.9.2 Satsuma CGRP Inhibitor Product Offered
11.9.3 Satsuma CGRP Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Satsuma Main Business Overview
11.9.5 Satsuma Latest Developments
11.10 Zosano Pharma
11.10.1 Zosano Pharma Company Information
11.10.2 Zosano Pharma CGRP Inhibitor Product Offered
11.10.3 Zosano Pharma CGRP Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Zosano Pharma Main Business Overview
11.10.5 Zosano Pharma Latest Developments
11.11 Dr.Reddy’s Laboratories
11.11.1 Dr.Reddy’s Laboratories Company Information
11.11.2 Dr.Reddy’s Laboratories CGRP Inhibitor Product Offered
11.11.3 Dr.Reddy’s Laboratories CGRP Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Dr.Reddy’s Laboratories Main Business Overview
11.11.5 Dr.Reddy’s Laboratories Latest Developments
12 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. CGRP Inhibitor Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. CGRP Inhibitor Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Infusions
Table 4. Major Players of Oral
Table 5. Major Players of Other
Table 6. CGRP Inhibitor Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global CGRP Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 8. Global CGRP Inhibitor Market Size Market Share by Type (2020-2025)
Table 9. CGRP Inhibitor Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global CGRP Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 11. Global CGRP Inhibitor Market Size Market Share by Application (2020-2025)
Table 12. Global CGRP Inhibitor Revenue by Player (2020-2025) & ($ millions)
Table 13. Global CGRP Inhibitor Revenue Market Share by Player (2020-2025)
Table 14. CGRP Inhibitor Key Players Head office and Products Offered
Table 15. CGRP Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global CGRP Inhibitor Market Size by Region (2020-2025) & ($ millions)
Table 19. Global CGRP Inhibitor Market Size Market Share by Region (2020-2025)
Table 20. Global CGRP Inhibitor Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global CGRP Inhibitor Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas CGRP Inhibitor Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas CGRP Inhibitor Market Size Market Share by Country (2020-2025)
Table 24. Americas CGRP Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas CGRP Inhibitor Market Size Market Share by Type (2020-2025)
Table 26. Americas CGRP Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas CGRP Inhibitor Market Size Market Share by Application (2020-2025)
Table 28. APAC CGRP Inhibitor Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC CGRP Inhibitor Market Size Market Share by Region (2020-2025)
Table 30. APAC CGRP Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC CGRP Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe CGRP Inhibitor Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe CGRP Inhibitor Market Size Market Share by Country (2020-2025)
Table 34. Europe CGRP Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe CGRP Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa CGRP Inhibitor Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa CGRP Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa CGRP Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of CGRP Inhibitor
Table 40. Key Market Challenges & Risks of CGRP Inhibitor
Table 41. Key Industry Trends of CGRP Inhibitor
Table 42. Global CGRP Inhibitor Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global CGRP Inhibitor Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global CGRP Inhibitor Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global CGRP Inhibitor Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. AbbVie Details, Company Type, CGRP Inhibitor Area Served and Its Competitors
Table 47. AbbVie CGRP Inhibitor Product Offered
Table 48. AbbVie CGRP Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. AbbVie Main Business
Table 50. AbbVie Latest Developments
Table 51. Amgen Details, Company Type, CGRP Inhibitor Area Served and Its Competitors
Table 52. Amgen CGRP Inhibitor Product Offered
Table 53. Amgen CGRP Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Amgen Main Business
Table 55. Amgen Latest Developments
Table 56. Eli Lilly Details, Company Type, CGRP Inhibitor Area Served and Its Competitors
Table 57. Eli Lilly CGRP Inhibitor Product Offered
Table 58. Eli Lilly CGRP Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Eli Lilly Main Business
Table 60. Eli Lilly Latest Developments
Table 61. Teva Pharmaceutical Details, Company Type, CGRP Inhibitor Area Served and Its Competitors
Table 62. Teva Pharmaceutical CGRP Inhibitor Product Offered
Table 63. Teva Pharmaceutical CGRP Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Teva Pharmaceutical Main Business
Table 65. Teva Pharmaceutical Latest Developments
Table 66. Pfizer Details, Company Type, CGRP Inhibitor Area Served and Its Competitors
Table 67. Pfizer CGRP Inhibitor Product Offered
Table 68. Pfizer CGRP Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Pfizer Main Business
Table 70. Pfizer Latest Developments
Table 71. Lundbeck Details, Company Type, CGRP Inhibitor Area Served and Its Competitors
Table 72. Lundbeck CGRP Inhibitor Product Offered
Table 73. Lundbeck CGRP Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Lundbeck Main Business
Table 75. Lundbeck Latest Developments
Table 76. Novartis Details, Company Type, CGRP Inhibitor Area Served and Its Competitors
Table 77. Novartis CGRP Inhibitor Product Offered
Table 78. Novartis CGRP Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Novartis Main Business
Table 80. Novartis Latest Developments
Table 81. Bristol Myers Squibb Details, Company Type, CGRP Inhibitor Area Served and Its Competitors
Table 82. Bristol Myers Squibb CGRP Inhibitor Product Offered
Table 83. Bristol Myers Squibb CGRP Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Bristol Myers Squibb Main Business
Table 85. Bristol Myers Squibb Latest Developments
Table 86. Satsuma Details, Company Type, CGRP Inhibitor Area Served and Its Competitors
Table 87. Satsuma CGRP Inhibitor Product Offered
Table 88. Satsuma CGRP Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Satsuma Main Business
Table 90. Satsuma Latest Developments
Table 91. Zosano Pharma Details, Company Type, CGRP Inhibitor Area Served and Its Competitors
Table 92. Zosano Pharma CGRP Inhibitor Product Offered
Table 93. Zosano Pharma CGRP Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Zosano Pharma Main Business
Table 95. Zosano Pharma Latest Developments
Table 96. Dr.Reddy’s Laboratories Details, Company Type, CGRP Inhibitor Area Served and Its Competitors
Table 97. Dr.Reddy’s Laboratories CGRP Inhibitor Product Offered
Table 98. Dr.Reddy’s Laboratories CGRP Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Dr.Reddy’s Laboratories Main Business
Table 100. Dr.Reddy’s Laboratories Latest Developments


List of Figures
Figure 1. CGRP Inhibitor Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CGRP Inhibitor Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. CGRP Inhibitor Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. CGRP Inhibitor Sales Market Share by Country/Region (2024)
Figure 8. CGRP Inhibitor Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global CGRP Inhibitor Market Size Market Share by Type in 2024
Figure 10. CGRP Inhibitor in Hospital
Figure 11. Global CGRP Inhibitor Market: Hospital (2020-2025) & ($ millions)
Figure 12. CGRP Inhibitor in Retail Pharmacy
Figure 13. Global CGRP Inhibitor Market: Retail Pharmacy (2020-2025) & ($ millions)
Figure 14. CGRP Inhibitor in Others
Figure 15. Global CGRP Inhibitor Market: Others (2020-2025) & ($ millions)
Figure 16. Global CGRP Inhibitor Market Size Market Share by Application in 2024
Figure 17. Global CGRP Inhibitor Revenue Market Share by Player in 2024
Figure 18. Global CGRP Inhibitor Market Size Market Share by Region (2020-2025)
Figure 19. Americas CGRP Inhibitor Market Size 2020-2025 ($ millions)
Figure 20. APAC CGRP Inhibitor Market Size 2020-2025 ($ millions)
Figure 21. Europe CGRP Inhibitor Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa CGRP Inhibitor Market Size 2020-2025 ($ millions)
Figure 23. Americas CGRP Inhibitor Value Market Share by Country in 2024
Figure 24. United States CGRP Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada CGRP Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico CGRP Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil CGRP Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC CGRP Inhibitor Market Size Market Share by Region in 2024
Figure 29. APAC CGRP Inhibitor Market Size Market Share by Type (2020-2025)
Figure 30. APAC CGRP Inhibitor Market Size Market Share by Application (2020-2025)
Figure 31. China CGRP Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan CGRP Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea CGRP Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia CGRP Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 35. India CGRP Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia CGRP Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe CGRP Inhibitor Market Size Market Share by Country in 2024
Figure 38. Europe CGRP Inhibitor Market Size Market Share by Type (2020-2025)
Figure 39. Europe CGRP Inhibitor Market Size Market Share by Application (2020-2025)
Figure 40. Germany CGRP Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 41. France CGRP Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 42. UK CGRP Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy CGRP Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia CGRP Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa CGRP Inhibitor Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa CGRP Inhibitor Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa CGRP Inhibitor Market Size Market Share by Application (2020-2025)
Figure 48. Egypt CGRP Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa CGRP Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel CGRP Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey CGRP Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries CGRP Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 54. APAC CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 55. Europe CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 57. United States CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 58. Canada CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 59. Mexico CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 60. Brazil CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 61. China CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 62. Japan CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 63. Korea CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 65. India CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 66. Australia CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 67. Germany CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 68. France CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 69. UK CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 70. Italy CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 71. Russia CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 72. Egypt CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 73. South Africa CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 74. Israel CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 75. Turkey CGRP Inhibitor Market Size 2026-2031 ($ millions)
Figure 76. Global CGRP Inhibitor Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global CGRP Inhibitor Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries CGRP Inhibitor Market Size 2026-2031 ($ millions)